Quantcast

Ralph Hasenhuttl plays down links of him replacing Ole Gunnar Solskjaer at Manchester United

Ralph Hasenhuttl plays down links of him replacing Ole Gunnar Solskjaer at Manchester United as Austrian claims there is 'something special growing' at Southampton Ralph...
More

    Australian wife of disgraced Hillsong pastor Carl Lentz is all smiles as she celebrates Thanksgiving

    Australian wife of disgraced Hillsong pastor Carl Lentz beams while celebrating Thanksgiving in Los Angeles - as the couple attempt to rebuild their marriage...

    Euphoria star Sydney Sweeney puts on a busty display in bikini with beau Jonathan Davino in Maui

    Euphoria star Sydney Sweeney puts on a busty display in a black bikini as she packs on the PDA with longtime beau Jonathan Davino...

    Donald Trump’s tiny desk sparks hilarious memes as he finally admits he will leave the White House 

    'Donald Trump was moved to the kiddie table this Thanksgiving': The president's tiny desk sparks hilarious memes as he gives testy White House press...

    Pfizer CEO says company didn’t conspire with anyone in timing of vaccine trial data release

    Pfizer CEO says company ‘didn’t conspire with anyone’ after Trump accused the ‘medical deep state’ of delaying releasing vaccine trial results until after the election

    • Pfizer CEO Albert Bourla spoke out in a New York Times conference on Tuesday
    • Said company ‘didn’t conspire with anyone’ to delay releasing efficacy results
    • Pfizer’s trial results were released two days after Biden was declared winner
    • The company had previously said the results would be known by October
    • Bourla also drew scrutiny for selling 60% of his Pfizer shares on the same day
    • The trade was pre-arranged under a plan Bourla adopted in August

    The CEO of drugmaker Pfizer has claimed the company ‘didn’t conspire with anyone’ to delay releasing efficacy results for its COVID-19 vaccine until after the U.S. presidential election.

    ‘We didn’t conspire with anyone, of course. The election was an artificial line. It may have been important to the president, but it wasn’t for us,’ CEO Albert Bourla said at a conference on Tuesday.

    Pfizer drew scrutiny after announcing trial results showing its vaccine is 90 percent effective on November 9, two days after Joe Biden was declared winner of the election, despite previously insisting the results would be known by the end of October.

    President Donald Trump raged at the discrepancy, accusing the Food and Drug Administration of imposing restrictions to delay the results of the trial.

    ‘We didn’t conspire with anyone, of course. The election was an artificial line. It may have been important to the president, but it wasn’t for us,’ Pfizer CEO Albert Bourla said at a conference on Tuesday

    President Donald Trump raged that the 'medical deep state' had conspired and lost him the election, pointing to Pfizer's news about a vaccine breakthrough, which came six days after voters went to the polls

    President Donald Trump raged that the ‘medical deep state’ had conspired and lost him the election, pointing to Pfizer’s news about a vaccine breakthrough, which came six days after voters went to the polls 

    ‘As I have long said, @Pfizer and the others would only announce a Vaccine after the Election, because they didn’t have the courage to do it before,’ he tweeted after the results were published. ‘Likewise, the @US_FDA should have announced it earlier, not for political purposes, but for saving lives!’ 

    PFIZER VACCINE TIMELINE 

    SEPTEMBER 13: Pfizer CEO Anthony Bourla says they will know if the vaccine is effective by the end of October 

    OCTOBER 16: In an open letter, Bourla promises again to know if the vaccine is effective by the end of October

    He said the company wouldn’t know if all three components – efficacy, safety and manufacturing – were up to par until the third week of November 

    OCTOBER 30-NOVEMBER 8: No update on efficacy of the vaccine 

    NOVEMBER 3: Presidential election 

    NOVEMBER 7: The election is called for Joe Biden 

    NOVEMBER 9: Pfizer announces results of efficacy study, says they expanded perimeters of it after consulting the FDA but doesn’t say when or why

    Advertisement

    ‘The @US_FDA and the Democrats didn’t want to have me get a Vaccine WIN, prior to the election, so instead it came out five days later –  As I’ve said all along!’ Trump added. 

    Bourla also came under scrutiny after it was revealed that he sold 60 percent of his Pfizer shares on the same day that the trial results were announced.

    It was part of a pre-arranged trade that he set up in August, but the timing of the vaccine trial announcement allowed him to cash in on the surge in Pfizer’s share price.

    On Tuesday, speaking at the New York Times’ DealBook conference, Bourla said that he didn’t take U.S. taxpayer dollars for the vaccine’s research and development in order to avoid politics that might be attached to the effort. 

    ‘When you want to go from the middle of next year to the middle of October, you need to remove any bureaucracy,’ he said. ‘And I knew this would become very political.’ 

    He did acknowledge that the U.S. government had committed to buying $2 billion worth of vaccine doses under Operation Warp Speed, but said that Pfizer had rejected any government funding in the research phase. 

    Pfizer’s vaccine was developed with German partner BioNTech SE. Bourla said the company is currently preparing that data for submission to the FDA.

    The Pfizer-BioNTech vaccine is slightly ahead of one from Moderna. 

    Vials of coronavirus disease (COVID-19) vaccine candidate are sorted at a Pfizer facility in Puurs, Belgium in an undated still image from video

    Vials of coronavirus disease (COVID-19) vaccine candidate are sorted at a Pfizer facility in Puurs, Belgium in an undated still image from video

    A technician inspects vials of coronavirus disease (COVID-19) vaccine candidate BNT162b2 at a Pfizer manufacturing site in manufacturing site in St. Louis, Missouri

    A technician inspects vials of coronavirus disease (COVID-19) vaccine candidate BNT162b2 at a Pfizer manufacturing site in manufacturing site in St. Louis, Missouri

    Moderna announced Monday that its own candidate was 94.5 percent effective. 

    Moderna expects to get the safety data it needs by the end of the month, allowing it to file for emergency clearance in the coming weeks.

    Bourla also said Pfizer has already hit the required safety milestone for the vaccine’s phase 3 trial, which is two months of data from around half of the study’s roughly 44,000 participants. 

    However, he said that there were still important questions about the vaccine that remain to be answered, such as how long it protects against the virus. 

    ‘When it comes to how durable the protection could be, this is something we don’t know yet,’ he said. 

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest Posts

    DAILY MAIL COMMENT: This mass shutdown defies logic, Prime Minister 

    DAILY MAIL COMMENT: This mass shutdown defies logic, Prime Minister By Daily Mail Comment Published: 09:58 GMT, 28 November 2020 |...

    Elderly patients are still given ‘Do Not Resuscitate’ orders against their or their families’ wishes

    Condemned by a 'care pathway'... again: Elderly patients are still given 'Do Not Resuscitate' orders against their or their families' wishes as this 93-year-old's...

    Mike Tyson vs Roy Jones Jr predictions: From David Haye to Evander Holyfield

    Mike Tyson returns to the ring against Roy Jones Jr TONIGHT... but can he still do it at the age of 54? Floyd Mayweather,...

    Lauren Goodger boasts about her ‘massive’ cleavage as she promotes X-rated subscription page

    'Yes they're massive': Lauren Goodger boasts about her VERY ample cleavage as she continues to promote her latest X-rated subscription page By Niomi Harris For...